Treatments

Image of a scientist doing research on a clinical trial.

New Clinical Trial Testing a Repurposing Drug, Proglumide, Aims to Treat Pain in Chronic Pancreatitis

Acute pancreatitis, a life-threatening condition, occurs suddenly and is often idiopathic (meaning, for unknown reasons). Although treatment specific to the disease is lacking, it usually resolves with proper clinical management. Multiple episodes may occur over time, leading to recurrent acute pancreatitis, which can eventually lead to chronic pancreatitis. Chronic pancreatitis is irreversible inflammatory and fibrotic

New Clinical Trial Testing a Repurposing Drug, Proglumide, Aims to Treat Pain in Chronic Pancreatitis Read More »

Image of Mission: Cure staff at Pancreasfest

Getting Ready to Test New Pancreatitis Treatments: News from PancreasFest

When will we have new treatments for pancreatitis? In July, Mission: Cure met with researchers and doctors to discuss this important question. Mission: Cure CEO Megan Golden, VP for Translational Research Lola Rahib, and the summer interns attended PancreasFest 2022 at the University of Pittsburgh. PancreasFest is an annual conference that brings together researchers who

Getting Ready to Test New Pancreatitis Treatments: News from PancreasFest Read More »

New Collaboration with Johns Hopkins to Treat Pancreatitis Pain

Mission: Cure has provided initial funding to Johns Hopkins Medicine to launch the new Pancreatitis Pain Research Center. Mission: Cure will work with Johns Hopkins to establish the Pancreatitis Pain Research Program. The goals for the pancreatitis pain program are: To study and treat specific types of pain associated with chronic pancreatitis To create an

New Collaboration with Johns Hopkins to Treat Pancreatitis Pain Read More »

Image of John Mellnik, CEO of Path BioAnalytics (PBA) with the text "Webinar" in the upper left corner and "New Therapies For Pancreatitis" in the middle.

New Therapies for Pancreatitis

Webinar: “New Therapies For Pancreatitis” https://youtu.be/I7XM-fdapvs Mission: Cure’s webinar on February 23rd, 2022 featured three biotech executives who are searching for a cure for pancreatitis and one of its major complications, diabetes. John Mellnik, CEO of Path BioAnalytics (PBA), discusses their most recent project that uses translational science and proprietary technology to identify drugs that

New Therapies for Pancreatitis Read More »

Image of Healx staff who are working on a pancreatitis treatment.

Discovering and Advancing the World’s First Treatments for Chronic Pancreatitis with Healx

We are elated to announce that Healx, an AI-powered technology company that shares our passion for patient-centered care, has chosen to team up with Mission: Cure to help find a cure for chronic pancreatitis! Mission: Cure was chosen from among many rare disease organizations to be part of Healx’s Rare Treatment Accelerator Program (RTA) with

Discovering and Advancing the World’s First Treatments for Chronic Pancreatitis with Healx Read More »

Drug Development With a Patient Focus

Pancreatitis Externally-Led Patient-Focused Drug Development Meeting Mission: Cure was one of many patient advocacy nonprofit organizations that participated in the development of the very first Voice of the Patient Report, a months-long project led by the National Pancreas Foundation. In March, during the Patient-Focused Drug Development (PFDD) meeting, Co-Founder and pancreatitis patient Eric Golden shared

Drug Development With a Patient Focus Read More »

Pancreatitis Pain: The Latest Treatment & Policy Perspectives on Opioids

On this webinar, Kate Nicholson, J.D., a civil rights attorney, pain patient advocate, and expert on the so-called opioid or overdose crisis, and Dr. Eva Szigethy, a leading UPMC psychiatrist focused on the management of chronic pain and psychotropic medication management in patients, discuss: Barriers to care for patients who use opioids The opioids policy

Pancreatitis Pain: The Latest Treatment & Policy Perspectives on Opioids Read More »

Potential Chronic Pancreatitis Treatments Identified

On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month “datathon” aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures

Potential Chronic Pancreatitis Treatments Identified Read More »

Scroll to Top

Before You Go

Get Updates in Your Inbox

Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.







I am a...: